Vascular Medicine News

Novo Nordisk and the FDA announced approval of a new indication for semaglutide 2.4 mg for reduction of risk for major adverse cardiovascular events in adults with overweight or obesity and established CVD.

With the beginning of daylight savings time impending, the American Heart Association issued recommendations for healthful behaviors to avoid any adverse cardiovascular effects from the time change.

Any amount of daily steps above 2,200 offers health benefits, but the step count associated with the lowest mortality and incident CVD risk was between 9,000 to 10,500 a day, research showed.

The use of BP medication among people who reported having high blood pressure increased by about 3 percentage points, according to a study in MMWR.

The combination of abnormal baseline global longitudinal strain and N-terminal-pro-B-type natriuretic peptide is associated with a more than fourfold risk for subsequent cardiomyopathy among certain childhood cancer survivors.

Among patients with asymptomatic carotid artery disease who had carotid endarterectomy, those whose atheromas contained microplastics and/or nanoplastics had worse outcomes than those whose atheromas did not, researchers reported.

In a cohort of American Indian individuals, more than 70% of young adults and more than 50% of adolescents had dyslipidemia, and some had subclinical or clinical heart disease, according to new data from the Strong Heart Study.

Editor’s Note: This is part 2 of a two-part Healio Exclusive series on renal denervation for hypertension control. Part 1 can be viewed here .

Alnylam announced that the KARDIA-2 phase 2 trial of its novel injectable antihypertensive drug zilebesiran met its primary endpoint.

Among patients with stable chest pain referred for invasive coronary angiography, a low coronary artery calcium score was associated with low risk for heart attack and stroke, researchers reported in Radiology.